Sage Therapeutics to Present at the Cowen 42nd Annual Healthcare Conference
February 28 2022 - 3:05PM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company committed to developing novel therapies with the potential
to transform the lives of people with debilitating disorders of the
brain, announced today that the Company will participate in a
fireside chat at the Cowen 42nd Annual Healthcare Conference on
Monday, March 7, 2022 at 10:30am ET.
A live webcast of the fireside chat can be accessed on the
Investor page of Sage’s website at investor.sagerx.com. A replay of
the webcast will be available approximately two hours after the
completion of the event and will be archived for up to 30 days.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company fearlessly leading the way to create a
world with better brain health. Our mission is to pioneer solutions
to deliver life-changing brain health medicines, so every person
can thrive. For more information, please visit. www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220224006092/en/
Investor Contact Helen Rubinstein 315-382-3979
helen.rubinstein@sagerx.com
Media Contact Maureen L. Suda 617-949-4289
maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024